Co-diagnostics, inc. (CODX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Dec'16
ASSETS:
Current Assets
Cash and cash equivalents

17,369

893

2,544

3,856

5,412

950

2,176

1,528

2,541

3,534

4,625

116

998

Accounts receivables, net

1,055

131

60

62

42

13

-

-

-

-

-

-

-

Other receivables

-

-

-

-

-

-

2

26

23

-

-

-

-

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

3

Other receivables

-

-

-

-

-

-

-

-

-

-

1

2

-

Inventory

686

197

17

8

18

18

0

0

0

9

45

-

0

Prepaid expenses

499

362

462

633

103

70

211

225

579

908

1,240

194

206

Total current assets

19,610

1,584

3,084

4,560

5,577

1,051

2,390

1,779

3,144

4,451

5,912

313

1,208

Other Assets
Property and equipment, net

276

186

179

172

135

156

140

150

162

165

139

154

87

Investment in joint venture

593

434

547

585

-

345

-

-

-

-

-

-

-

Investment in joint venture

-

-

-

-

408

-

182

39

19

44

-

-

0

Total other assets

869

631

727

757

544

501

322

189

182

210

-

-

87

Total assets

20,480

2,215

3,811

5,317

6,121

1,553

2,713

1,969

3,327

4,662

6,052

467

1,295

LIABILITIES AND STOCKHOLER'S EQUITY:
Current Liabilities
Accounts payable

132

5

21

35

96

148

66

33

35

40

80

115

29

Accounts payable (related party)

-

-

-

-

-

-

-

-

-

-

0

75

75

Accrued expenses

496

200

161

156

121

174

95

98

91

96

65

222

101

Accrued expenses (related party)

120

120

120

120

120

120

120

120

120

480

520

814

690

Current notes payable net of $0 and $91,427 discount, respectively

-

-

-

-

-

1,908

1,869

-

-

-

0

2,640

2,111

Deferred revenue

444

1

4

-

-

-

-

-

-

-

-

-

-

Notes payable net of discount of $0 and $91,428

-

-

-

-

-

-

-

-

-

-

0

795

837

Deferred income current

-

-

-

-

-

-

39

39

39

10

10

10

0

Total current liabilities

1,193

328

307

312

337

2,351

2,189

290

286

628

677

4,674

3,845

Long-term Liabilities, net of current portion
Accrued expenses-long-term (related party)

120

150

170

200

220

260

270

-

-

-

-

-

-

Accrued expenses-long-term (related party)

-

-

-

-

-

-

-

300

330

-

-

-

-

Notes payable long-term

-

-

-

-

-

-

-

-

-

-

0

0

445

Deferred income long-term

-

-

-

-

-

-

126

135

145

183

186

188

0

Total long-term liabilities, net of current portion

120

150

170

200

220

260

396

435

475

183

186

188

445

Total liabilities

1,313

478

477

512

557

2,611

2,586

726

761

811

863

4,862

4,290

Commitments and contingencies

-

-

-

-

-

-

0

-

0

-

0

-

0

STOCKHOLDERS' EQUITY (DEFICIT):
Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized, 0 and 25,600 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

-

0

0

0

0

-

-

-

-

-

-

-

-

Common stock, $0.001 par value, 100,000,000 shares authorized; 27,451,064 and 17,342,922 shares issued and outstanding, as of March 31, 2020 and December 31, 2019, respectively.

27

17

17

17

17

12

12

12

12

12

12

9

9

Additional paid-in capital

45,172

26,687

26,471

26,195

25,609

17,622

-

-

-

16,260

-

-

-

Additional paid-in capital

-

-

-

-

-

-

16,860

16,335

16,285

-

16,094

2,618

2,458

Accumulated deficit

-26,033

-24,967

-23,154

-21,406

-20,062

-18,694

-16,745

-15,104

-13,732

-12,422

-10,917

-7,023

-5,463

Total stockholders' equity

19,166

1,737

3,333

4,805

5,563

-1,058

127

1,243

2,565

3,850

5,189

-4,395

-2,994

Total liabilities and stockholders' equity

20,480

2,215

3,811

5,317

6,121

1,553

2,713

1,969

3,327

4,662

6,052

467

1,295